| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kenya | 86 | 2020 | 476 | 4.670 |
Why?
|
| Rural Population | 39 | 2018 | 1728 | 2.530 |
Why?
|
| Tuberculosis | 27 | 2020 | 1574 | 2.230 |
Why?
|
| Menstrual Hygiene Products | 6 | 2019 | 17 | 2.070 |
Why?
|
| Rotavirus Infections | 8 | 2016 | 90 | 1.770 |
Why?
|
| Menstruation | 7 | 2019 | 281 | 1.600 |
Why?
|
| Tuberculosis, Pulmonary | 18 | 2015 | 822 | 1.390 |
Why?
|
| Gastroenteritis | 6 | 2014 | 258 | 1.380 |
Why?
|
| Malaria | 13 | 2019 | 950 | 1.170 |
Why?
|
| Population Surveillance | 22 | 2019 | 2714 | 1.160 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 14 | 2012 | 827 | 1.120 |
Why?
|
| Disease Outbreaks | 15 | 2020 | 1585 | 1.020 |
Why?
|
| Child Mortality | 6 | 2018 | 223 | 0.930 |
Why?
|
| Directly Observed Therapy | 6 | 2008 | 155 | 0.910 |
Why?
|
| Emigration and Immigration | 7 | 2012 | 367 | 0.900 |
Why?
|
| Malaria, Falciparum | 10 | 2018 | 861 | 0.890 |
Why?
|
| HIV Infections | 38 | 2019 | 14118 | 0.890 |
Why?
|
| Rotavirus Vaccines | 5 | 2012 | 65 | 0.880 |
Why?
|
| Vaccination | 10 | 2019 | 1909 | 0.860 |
Why?
|
| Prenatal Care | 6 | 2019 | 940 | 0.850 |
Why?
|
| Diarrhea | 8 | 2020 | 1258 | 0.800 |
Why?
|
| Antitubercular Agents | 14 | 2012 | 1216 | 0.780 |
Why?
|
| Midwifery | 3 | 2018 | 113 | 0.770 |
Why?
|
| Cause of Death | 11 | 2018 | 3274 | 0.760 |
Why?
|
| Vaginosis, Bacterial | 3 | 2017 | 99 | 0.760 |
Why?
|
| Sexually Transmitted Diseases | 3 | 2016 | 496 | 0.740 |
Why?
|
| Tuberculin Test | 7 | 2019 | 195 | 0.740 |
Why?
|
| Patient Acceptance of Health Care | 12 | 2019 | 2669 | 0.730 |
Why?
|
| Communicable Disease Control | 7 | 2013 | 610 | 0.690 |
Why?
|
| Communicable Diseases | 6 | 2014 | 692 | 0.690 |
Why?
|
| Pneumococcal Infections | 3 | 2017 | 536 | 0.680 |
Why?
|
| Family Characteristics | 5 | 2019 | 884 | 0.670 |
Why?
|
| Data Collection | 12 | 2017 | 3301 | 0.660 |
Why?
|
| Mycobacterium tuberculosis | 16 | 2019 | 1693 | 0.640 |
Why?
|
| Pneumococcal Vaccines | 3 | 2017 | 406 | 0.630 |
Why?
|
| Ownership | 2 | 2015 | 270 | 0.630 |
Why?
|
| House Calls | 2 | 2013 | 112 | 0.620 |
Why?
|
| AIDS-Related Opportunistic Infections | 6 | 2011 | 688 | 0.610 |
Why?
|
| AIDS Serodiagnosis | 3 | 2013 | 217 | 0.600 |
Why?
|
| India | 21 | 2019 | 1929 | 0.600 |
Why?
|
| Epidemiologic Research Design | 1 | 2018 | 353 | 0.580 |
Why?
|
| Weather | 1 | 2015 | 213 | 0.570 |
Why?
|
| Vaccines, Conjugate | 1 | 2015 | 324 | 0.570 |
Why?
|
| Hygiene | 3 | 2019 | 90 | 0.570 |
Why?
|
| Sputum | 8 | 2012 | 445 | 0.560 |
Why?
|
| Politics | 3 | 2010 | 731 | 0.550 |
Why?
|
| BCG Vaccine | 4 | 2020 | 290 | 0.550 |
Why?
|
| Demography | 7 | 2014 | 1536 | 0.540 |
Why?
|
| Adolescent | 75 | 2019 | 79142 | 0.530 |
Why?
|
| Occupations | 1 | 2015 | 448 | 0.530 |
Why?
|
| Indians, South American | 4 | 1999 | 49 | 0.530 |
Why?
|
| Abscess | 1 | 2015 | 553 | 0.510 |
Why?
|
| Directive Counseling | 2 | 2013 | 181 | 0.500 |
Why?
|
| Violence | 2 | 2010 | 909 | 0.490 |
Why?
|
| Infant | 45 | 2020 | 31535 | 0.480 |
Why?
|
| Rural Health Services | 5 | 2013 | 358 | 0.470 |
Why?
|
| Democracy | 1 | 2010 | 22 | 0.460 |
Why?
|
| Hematologic Tests | 1 | 2011 | 217 | 0.450 |
Why?
|
| Mass Screening | 12 | 2015 | 4807 | 0.450 |
Why?
|
| Continuity of Patient Care | 1 | 2018 | 1010 | 0.450 |
Why?
|
| Artemisinins | 5 | 2018 | 209 | 0.430 |
Why?
|
| Litchi | 3 | 2017 | 3 | 0.430 |
Why?
|
| Plasmodium falciparum | 10 | 2018 | 1536 | 0.420 |
Why?
|
| Child, Preschool | 38 | 2020 | 38643 | 0.410 |
Why?
|
| Schools | 6 | 2019 | 1042 | 0.410 |
Why?
|
| Risk-Taking | 1 | 2015 | 1004 | 0.410 |
Why?
|
| Blood Chemical Analysis | 1 | 2011 | 472 | 0.410 |
Why?
|
| Insecticide-Treated Bednets | 3 | 2016 | 45 | 0.410 |
Why?
|
| Humans | 162 | 2020 | 627531 | 0.400 |
Why?
|
| Neurotoxicity Syndromes | 3 | 2017 | 242 | 0.400 |
Why?
|
| Anemia | 4 | 2019 | 1296 | 0.400 |
Why?
|
| Water Supply | 4 | 2018 | 209 | 0.400 |
Why?
|
| Prevalence | 27 | 2019 | 13874 | 0.400 |
Why?
|
| Regional Health Planning | 1 | 2009 | 95 | 0.400 |
Why?
|
| Female | 114 | 2020 | 352544 | 0.390 |
Why?
|
| Sanitation | 2 | 2018 | 74 | 0.390 |
Why?
|
| Home Care Services | 1 | 2013 | 470 | 0.380 |
Why?
|
| Antimalarials | 7 | 2018 | 767 | 0.380 |
Why?
|
| Young Adult | 38 | 2019 | 50739 | 0.370 |
Why?
|
| Administrative Personnel | 1 | 2009 | 165 | 0.370 |
Why?
|
| Abortion, Spontaneous | 3 | 2016 | 426 | 0.370 |
Why?
|
| Refugees | 2 | 2010 | 336 | 0.370 |
Why?
|
| Health Knowledge, Attitudes, Practice | 12 | 2019 | 3891 | 0.370 |
Why?
|
| Autopsy | 5 | 2018 | 857 | 0.350 |
Why?
|
| Student Dropouts | 2 | 2016 | 30 | 0.350 |
Why?
|
| Absenteeism | 3 | 2019 | 256 | 0.350 |
Why?
|
| Staff Development | 1 | 2009 | 228 | 0.340 |
Why?
|
| Rifampin | 5 | 2009 | 276 | 0.340 |
Why?
|
| Rural Health | 5 | 2016 | 299 | 0.340 |
Why?
|
| Immunization Programs | 4 | 2020 | 251 | 0.340 |
Why?
|
| Social Class | 2 | 2015 | 1867 | 0.340 |
Why?
|
| Insecticides | 4 | 2016 | 204 | 0.340 |
Why?
|
| Anthrax | 3 | 2019 | 99 | 0.330 |
Why?
|
| Infant, Newborn | 21 | 2020 | 22211 | 0.330 |
Why?
|
| Students, Nursing | 1 | 2005 | 29 | 0.320 |
Why?
|
| Operations Research | 1 | 2005 | 20 | 0.320 |
Why?
|
| Mortality | 3 | 2014 | 2529 | 0.320 |
Why?
|
| Adult | 75 | 2019 | 199203 | 0.320 |
Why?
|
| Betaine | 1 | 2005 | 83 | 0.320 |
Why?
|
| Students | 4 | 2018 | 1370 | 0.310 |
Why?
|
| National Health Programs | 2 | 2007 | 466 | 0.300 |
Why?
|
| Male | 92 | 2020 | 333300 | 0.300 |
Why?
|
| Menarche | 3 | 2018 | 479 | 0.290 |
Why?
|
| Public Health | 2 | 2008 | 2089 | 0.290 |
Why?
|
| Multivariate Analysis | 13 | 2016 | 12970 | 0.290 |
Why?
|
| Anopheles | 6 | 2018 | 161 | 0.290 |
Why?
|
| Haemophilus Vaccines | 2 | 2014 | 73 | 0.280 |
Why?
|
| Pregnancy Complications | 3 | 2016 | 2694 | 0.280 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 2 | 2014 | 47 | 0.280 |
Why?
|
| Developing Countries | 9 | 2018 | 2563 | 0.280 |
Why?
|
| Preventive Health Services | 1 | 2009 | 575 | 0.280 |
Why?
|
| Reference Values | 1 | 2011 | 5221 | 0.270 |
Why?
|
| Vietnam | 6 | 2009 | 389 | 0.260 |
Why?
|
| Mosquito Control | 3 | 2013 | 81 | 0.260 |
Why?
|
| Seasons | 7 | 2016 | 1398 | 0.260 |
Why?
|
| Hepatitis B Vaccines | 2 | 2014 | 173 | 0.260 |
Why?
|
| Infant Mortality | 4 | 2018 | 751 | 0.260 |
Why?
|
| Cross-Sectional Studies | 15 | 2018 | 18899 | 0.260 |
Why?
|
| Diarrhea, Infantile | 2 | 2013 | 143 | 0.250 |
Why?
|
| Malaria Vaccines | 2 | 2012 | 120 | 0.250 |
Why?
|
| Chromatography, Thin Layer | 1 | 2001 | 251 | 0.240 |
Why?
|
| Health Services Accessibility | 5 | 2014 | 4524 | 0.240 |
Why?
|
| Fruit | 2 | 2017 | 1035 | 0.240 |
Why?
|
| Hepatitis E | 2 | 2019 | 69 | 0.240 |
Why?
|
| Vaccines, Attenuated | 5 | 2014 | 329 | 0.240 |
Why?
|
| Isoniazid | 2 | 2005 | 230 | 0.240 |
Why?
|
| Influenza, Human | 4 | 2017 | 1171 | 0.230 |
Why?
|
| Specimen Handling | 1 | 2005 | 647 | 0.230 |
Why?
|
| Henipavirus Infections | 1 | 2019 | 7 | 0.230 |
Why?
|
| Child | 32 | 2019 | 64301 | 0.220 |
Why?
|
| Bacillus anthracis | 3 | 2019 | 155 | 0.220 |
Why?
|
| Malaria, Vivax | 2 | 1999 | 122 | 0.220 |
Why?
|
| Feasibility Studies | 7 | 2018 | 4388 | 0.220 |
Why?
|
| Streptococcus pneumoniae | 2 | 2017 | 749 | 0.220 |
Why?
|
| Pregnancy | 16 | 2019 | 23544 | 0.220 |
Why?
|
| Pyrethrins | 2 | 2016 | 61 | 0.220 |
Why?
|
| Socioeconomic Factors | 10 | 2016 | 7536 | 0.220 |
Why?
|
| Livestock | 2 | 2019 | 18 | 0.210 |
Why?
|
| Scrub Typhus | 1 | 2018 | 1 | 0.210 |
Why?
|
| Orientia tsutsugamushi | 1 | 2018 | 2 | 0.210 |
Why?
|
| Encephalitis, Japanese | 1 | 2019 | 10 | 0.210 |
Why?
|
| Syphilis | 2 | 2019 | 207 | 0.210 |
Why?
|
| Anti-HIV Agents | 7 | 2018 | 3864 | 0.210 |
Why?
|
| Cross Infection | 2 | 2019 | 1336 | 0.210 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2019 | 1684 | 0.210 |
Why?
|
| Program Evaluation | 6 | 2014 | 2554 | 0.210 |
Why?
|
| Jaundice | 1 | 2019 | 94 | 0.210 |
Why?
|
| Risk Factors | 32 | 2019 | 64487 | 0.210 |
Why?
|
| Guidelines as Topic | 1 | 2006 | 1399 | 0.210 |
Why?
|
| Health Surveys | 6 | 2018 | 3988 | 0.210 |
Why?
|
| Soaps | 1 | 2018 | 21 | 0.210 |
Why?
|
| Escherichia coli Infections | 2 | 2020 | 555 | 0.210 |
Why?
|
| Colistin | 1 | 2019 | 79 | 0.210 |
Why?
|
| Cryptosporidium | 1 | 2018 | 24 | 0.200 |
Why?
|
| HIV | 5 | 2012 | 1366 | 0.200 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2019 | 58 | 0.200 |
Why?
|
| Klebsiella Infections | 1 | 2019 | 144 | 0.200 |
Why?
|
| Cryptosporidiosis | 1 | 2018 | 39 | 0.200 |
Why?
|
| Reagent Kits, Diagnostic | 2 | 2011 | 254 | 0.200 |
Why?
|
| Hepatitis E virus | 1 | 2019 | 68 | 0.200 |
Why?
|
| Cost of Illness | 4 | 2015 | 1669 | 0.200 |
Why?
|
| Floods | 1 | 2018 | 22 | 0.200 |
Why?
|
| Microbial Sensitivity Tests | 7 | 2017 | 1812 | 0.190 |
Why?
|
| Tuberculosis Vaccines | 1 | 2018 | 43 | 0.190 |
Why?
|
| DNA, Protozoan | 2 | 1999 | 232 | 0.190 |
Why?
|
| Men | 1 | 2017 | 54 | 0.190 |
Why?
|
| Klebsiella pneumoniae | 1 | 2019 | 267 | 0.190 |
Why?
|
| Africa | 6 | 2020 | 602 | 0.190 |
Why?
|
| International Cooperation | 5 | 2010 | 1558 | 0.180 |
Why?
|
| Lost to Follow-Up | 1 | 2018 | 104 | 0.180 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2014 | 1104 | 0.180 |
Why?
|
| Immunization Schedule | 3 | 2012 | 206 | 0.180 |
Why?
|
| Middle Aged | 48 | 2019 | 204499 | 0.180 |
Why?
|
| Time Factors | 13 | 2018 | 41572 | 0.180 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2018 | 169 | 0.180 |
Why?
|
| Terminology as Topic | 1 | 2005 | 1634 | 0.180 |
Why?
|
| Dengue Virus | 1 | 2019 | 193 | 0.170 |
Why?
|
| Mothers | 2 | 2018 | 1796 | 0.170 |
Why?
|
| Case-Control Studies | 14 | 2020 | 20360 | 0.170 |
Why?
|
| Health Facilities | 2 | 2018 | 332 | 0.170 |
Why?
|
| Sulfadoxine | 1 | 2015 | 39 | 0.170 |
Why?
|
| Measles Vaccine | 1 | 2016 | 85 | 0.160 |
Why?
|
| Pyrimethamine | 1 | 2015 | 80 | 0.160 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2015 | 48 | 0.160 |
Why?
|
| Perception | 4 | 2017 | 1019 | 0.160 |
Why?
|
| Kyasanur Forest Disease | 1 | 2015 | 1 | 0.160 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2019 | 602 | 0.160 |
Why?
|
| Enteritis | 1 | 2016 | 140 | 0.160 |
Why?
|
| Incidence | 11 | 2019 | 19135 | 0.160 |
Why?
|
| HIV Antibodies | 2 | 2012 | 1126 | 0.160 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2015 | 139 | 0.160 |
Why?
|
| Students, Medical | 1 | 2005 | 1373 | 0.150 |
Why?
|
| Guilt | 1 | 2014 | 89 | 0.150 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 619 | 0.150 |
Why?
|
| Caregivers | 3 | 2014 | 1340 | 0.150 |
Why?
|
| Pilot Projects | 6 | 2018 | 7195 | 0.150 |
Why?
|
| Perinatal Care | 1 | 2016 | 211 | 0.150 |
Why?
|
| Venezuela | 3 | 1999 | 63 | 0.150 |
Why?
|
| Feces | 5 | 2019 | 1160 | 0.150 |
Why?
|
| Measles | 1 | 2016 | 165 | 0.150 |
Why?
|
| Quinolines | 2 | 2018 | 689 | 0.150 |
Why?
|
| Disease Notification | 3 | 2012 | 99 | 0.150 |
Why?
|
| Occupational Exposure | 4 | 2005 | 1550 | 0.150 |
Why?
|
| Intention | 1 | 2016 | 271 | 0.140 |
Why?
|
| Neonatal Screening | 1 | 2018 | 485 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 3 | 2009 | 6618 | 0.140 |
Why?
|
| Insect Vectors | 2 | 2012 | 170 | 0.140 |
Why?
|
| Placebos | 4 | 2012 | 1742 | 0.140 |
Why?
|
| Sex Factors | 4 | 2013 | 10445 | 0.140 |
Why?
|
| Paternal Behavior | 1 | 2013 | 37 | 0.140 |
Why?
|
| Hookworm Infections | 1 | 2012 | 11 | 0.140 |
Why?
|
| Child Health Services | 2 | 2011 | 709 | 0.140 |
Why?
|
| Cambodia | 3 | 2008 | 188 | 0.140 |
Why?
|
| Focus Groups | 5 | 2015 | 1181 | 0.140 |
Why?
|
| Trichuriasis | 1 | 2012 | 24 | 0.130 |
Why?
|
| Rotavirus | 4 | 2016 | 100 | 0.130 |
Why?
|
| Mass Chest X-Ray | 2 | 2012 | 16 | 0.130 |
Why?
|
| Schistosomiasis | 1 | 2012 | 48 | 0.130 |
Why?
|
| Asia | 4 | 2014 | 603 | 0.130 |
Why?
|
| Vaginal Smears | 1 | 2016 | 476 | 0.130 |
Why?
|
| Antibiotics, Antitubercular | 3 | 2009 | 99 | 0.130 |
Why?
|
| Tennessee | 2 | 2012 | 121 | 0.130 |
Why?
|
| Anthelmintics | 1 | 2012 | 62 | 0.130 |
Why?
|
| Postal Service | 2 | 2002 | 100 | 0.130 |
Why?
|
| Qualitative Research | 5 | 2019 | 1910 | 0.130 |
Why?
|
| Public Sector | 3 | 2019 | 262 | 0.130 |
Why?
|
| Plasmodium malariae | 1 | 2011 | 12 | 0.130 |
Why?
|
| Dominican Republic | 3 | 2007 | 71 | 0.130 |
Why?
|
| Helminthiasis | 1 | 2012 | 69 | 0.130 |
Why?
|
| Ethanolamines | 2 | 2009 | 154 | 0.130 |
Why?
|
| Alcoholic Intoxication | 1 | 2013 | 179 | 0.130 |
Why?
|
| Age Distribution | 6 | 2014 | 2975 | 0.130 |
Why?
|
| Laboratories | 3 | 2010 | 352 | 0.130 |
Why?
|
| Social Stigma | 2 | 2014 | 487 | 0.130 |
Why?
|
| Rain | 4 | 2012 | 54 | 0.120 |
Why?
|
| Urban Health Services | 1 | 2013 | 184 | 0.120 |
Why?
|
| Administration, Oral | 4 | 2012 | 3869 | 0.120 |
Why?
|
| Maternal Health Services | 1 | 2016 | 395 | 0.120 |
Why?
|
| Sporozoites | 1 | 2011 | 66 | 0.120 |
Why?
|
| Bioterrorism | 2 | 2002 | 168 | 0.120 |
Why?
|
| Labor, Obstetric | 1 | 2013 | 278 | 0.120 |
Why?
|
| Principal Component Analysis | 1 | 2015 | 945 | 0.120 |
Why?
|
| Climate Change | 1 | 2015 | 230 | 0.120 |
Why?
|
| World Health Organization | 4 | 2016 | 1178 | 0.120 |
Why?
|
| Pregnancy Trimester, First | 1 | 2015 | 796 | 0.120 |
Why?
|
| Intussusception | 1 | 2012 | 120 | 0.120 |
Why?
|
| Fluorenes | 2 | 2009 | 148 | 0.120 |
Why?
|
| Medical Errors | 1 | 2000 | 1243 | 0.120 |
Why?
|
| Temperature | 2 | 2015 | 2062 | 0.120 |
Why?
|
| Needs Assessment | 1 | 2018 | 1158 | 0.120 |
Why?
|
| Vaccines, Synthetic | 1 | 2012 | 440 | 0.120 |
Why?
|
| Fluid Therapy | 2 | 2013 | 592 | 0.120 |
Why?
|
| Sexual Partners | 1 | 2015 | 648 | 0.120 |
Why?
|
| Colombia | 2 | 2001 | 180 | 0.120 |
Why?
|
| Multiple Trauma | 1 | 2013 | 370 | 0.120 |
Why?
|
| Clinical Medicine | 1 | 2012 | 153 | 0.110 |
Why?
|
| Postpartum Hemorrhage | 1 | 2013 | 193 | 0.110 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2019 | 883 | 0.110 |
Why?
|
| Sensitivity and Specificity | 9 | 2012 | 15109 | 0.110 |
Why?
|
| Delivery, Obstetric | 2 | 2016 | 774 | 0.110 |
Why?
|
| Alcohol Drinking | 2 | 2013 | 3566 | 0.110 |
Why?
|
| Drug Combinations | 4 | 2015 | 1529 | 0.110 |
Why?
|
| Hospitalization | 6 | 2016 | 7774 | 0.110 |
Why?
|
| Registries | 2 | 2007 | 7137 | 0.110 |
Why?
|
| Travel | 1 | 2016 | 691 | 0.110 |
Why?
|
| United States | 12 | 2016 | 59314 | 0.110 |
Why?
|
| Institutional Management Teams | 1 | 2009 | 32 | 0.110 |
Why?
|
| Family Health | 1 | 2015 | 1321 | 0.110 |
Why?
|
| Aged | 25 | 2019 | 150794 | 0.110 |
Why?
|
| Emigrants and Immigrants | 3 | 2012 | 376 | 0.110 |
Why?
|
| Age Factors | 8 | 2017 | 18670 | 0.100 |
Why?
|
| Epidemiologic Methods | 1 | 2015 | 1415 | 0.100 |
Why?
|
| Reminder Systems | 1 | 2012 | 389 | 0.100 |
Why?
|
| Inhalation Exposure | 2 | 2002 | 446 | 0.100 |
Why?
|
| Papillomavirus Vaccines | 1 | 2014 | 388 | 0.100 |
Why?
|
| Treatment Outcome | 15 | 2015 | 56549 | 0.100 |
Why?
|
| Congenital Abnormalities | 1 | 2013 | 679 | 0.100 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2000 | 827 | 0.100 |
Why?
|
| Brain Diseases | 1 | 2017 | 1496 | 0.100 |
Why?
|
| Sentinel Surveillance | 2 | 2007 | 290 | 0.100 |
Why?
|
| Immunization | 1 | 2012 | 1218 | 0.100 |
Why?
|
| Models, Statistical | 2 | 2014 | 4967 | 0.100 |
Why?
|
| Accidents, Traffic | 1 | 2013 | 730 | 0.100 |
Why?
|
| Double-Blind Method | 5 | 2012 | 11119 | 0.090 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2012 | 764 | 0.090 |
Why?
|
| Brazil | 3 | 2007 | 1248 | 0.090 |
Why?
|
| Peer Group | 1 | 2013 | 567 | 0.090 |
Why?
|
| Vaccines | 1 | 2013 | 483 | 0.090 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5931 | 0.090 |
Why?
|
| Reimbursement, Incentive | 1 | 2012 | 486 | 0.090 |
Why?
|
| Ambulatory Care Facilities | 2 | 2015 | 740 | 0.090 |
Why?
|
| Accreditation | 1 | 2010 | 400 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 2042 | 0.090 |
Why?
|
| Healthy People Programs | 1 | 2007 | 62 | 0.090 |
Why?
|
| Health Services Research | 3 | 2011 | 1862 | 0.090 |
Why?
|
| Malawi | 1 | 2007 | 197 | 0.090 |
Why?
|
| Parasitemia | 3 | 2009 | 152 | 0.090 |
Why?
|
| Nasopharynx | 3 | 2017 | 314 | 0.090 |
Why?
|
| Delivery of Health Care | 3 | 2012 | 3828 | 0.090 |
Why?
|
| Clinical Protocols | 1 | 2013 | 1420 | 0.090 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 1441 | 0.090 |
Why?
|
| Linear Models | 2 | 2016 | 6137 | 0.090 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2007 | 120 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4132 | 0.090 |
Why?
|
| Accidental Falls | 1 | 2013 | 898 | 0.080 |
Why?
|
| Benzophenoneidum | 1 | 2005 | 1 | 0.080 |
Why?
|
| Women's Health | 1 | 2016 | 1784 | 0.080 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2017 | 1013 | 0.080 |
Why?
|
| Sexual Behavior | 1 | 2016 | 1707 | 0.080 |
Why?
|
| Academies and Institutes | 1 | 2008 | 247 | 0.080 |
Why?
|
| Treatment Refusal | 2 | 2008 | 449 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 4697 | 0.080 |
Why?
|
| Counseling | 1 | 2014 | 1438 | 0.080 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 7727 | 0.080 |
Why?
|
| Escherichia coli | 1 | 2018 | 4440 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 3298 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2018 | 2728 | 0.080 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 38061 | 0.080 |
Why?
|
| Biological Assay | 1 | 2009 | 660 | 0.080 |
Why?
|
| Plasmodium vivax | 2 | 1999 | 160 | 0.080 |
Why?
|
| Problem-Based Learning | 1 | 2009 | 332 | 0.080 |
Why?
|
| Latent Tuberculosis | 2 | 2019 | 141 | 0.080 |
Why?
|
| Rwanda | 1 | 2007 | 600 | 0.080 |
Why?
|
| Residence Characteristics | 1 | 2014 | 1841 | 0.080 |
Why?
|
| Private Sector | 2 | 2005 | 361 | 0.080 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 1137 | 0.080 |
Why?
|
| Professional Competence | 1 | 2009 | 497 | 0.080 |
Why?
|
| Organizational Objectives | 1 | 2007 | 468 | 0.070 |
Why?
|
| HIV-1 | 2 | 2012 | 6525 | 0.070 |
Why?
|
| Drug Therapy, Combination | 5 | 2015 | 6452 | 0.070 |
Why?
|
| Geography | 2 | 2016 | 618 | 0.070 |
Why?
|
| Emergency Medicine | 1 | 2012 | 1022 | 0.070 |
Why?
|
| Health Plan Implementation | 1 | 2007 | 344 | 0.070 |
Why?
|
| Personnel, Hospital | 1 | 2005 | 270 | 0.070 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2014 | 1745 | 0.070 |
Why?
|
| Retrospective Studies | 14 | 2019 | 56996 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 3 | 2018 | 6279 | 0.070 |
Why?
|
| Predictive Value of Tests | 6 | 2012 | 14782 | 0.070 |
Why?
|
| CD4 Lymphocyte Count | 4 | 2013 | 2582 | 0.070 |
Why?
|
| Logistic Models | 5 | 2018 | 13715 | 0.070 |
Why?
|
| Proportional Hazards Models | 3 | 2012 | 11937 | 0.070 |
Why?
|
| Anti-Retroviral Agents | 1 | 2012 | 1454 | 0.070 |
Why?
|
| Risk | 1 | 2015 | 9850 | 0.060 |
Why?
|
| Europe, Eastern | 1 | 2001 | 46 | 0.060 |
Why?
|
| Animals | 13 | 2019 | 168063 | 0.060 |
Why?
|
| Geographic Information Systems | 2 | 2016 | 261 | 0.060 |
Why?
|
| Health Priorities | 1 | 2005 | 397 | 0.060 |
Why?
|
| Aged, 80 and over | 8 | 2019 | 55853 | 0.060 |
Why?
|
| Research Design | 2 | 2014 | 5482 | 0.060 |
Why?
|
|